annual working capital:
$393.67M+$190.76M(+94.01%)Summary
- As of today (July 1, 2025), SUPN annual working capital is $393.67 million, with the most recent change of +$190.76 million (+94.01%) on December 31, 2024.
- During the last 3 years, SUPN annual working capital has risen by +$107.46 million (+37.55%).
- SUPN annual working capital is now at all-time high.
Performance
SUPN Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$405.81M+$12.14M(+3.08%)Summary
- As of today (July 1, 2025), SUPN quarterly working capital is $405.81 million, with the most recent change of +$12.14 million (+3.08%) on March 31, 2025.
- Over the past year, SUPN quarterly working capital has increased by +$176.04 million (+76.62%).
- SUPN quarterly working capital is now -12.57% below its all-time high of $464.16 million, reached on March 31, 2018.
Performance
SUPN quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
SUPN Working capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +94.0% | +76.6% |
3 y3 years | +37.5% | +42.9% |
5 y5 years | +26.1% | +4.4% |
SUPN Working capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +752.2% | at high | +467.5% |
5 y | 5-year | at high | +752.2% | -6.4% | +467.5% |
alltime | all time | at high | +1499.8% | -12.6% | +467.5% |
SUPN Working capital History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $405.81M(+3.1%) |
Dec 2024 | $393.67M(+94.0%) | $393.67M(+13.0%) |
Sep 2024 | - | $348.50M(+23.4%) |
Jun 2024 | - | $282.35M(+22.9%) |
Mar 2024 | - | $229.77M(+13.2%) |
Dec 2023 | $202.92M(+339.3%) | $202.92M(+25.4%) |
Sep 2023 | - | $161.83M(-5.3%) |
Jun 2023 | - | $170.95M(+12.6%) |
Mar 2023 | - | $151.79M(+228.6%) |
Dec 2022 | $46.19M(-83.9%) | $46.19M(-174.4%) |
Sep 2022 | - | -$62.10M(-43.8%) |
Jun 2022 | - | -$110.42M(-138.9%) |
Mar 2022 | - | $283.96M(-0.8%) |
Dec 2021 | $286.21M(-25.7%) | $286.21M(-34.0%) |
Sep 2021 | - | $433.66M(+21.9%) |
Jun 2021 | - | $355.80M(+3.1%) |
Mar 2021 | - | $345.21M(-10.4%) |
Dec 2020 | $385.31M(+23.5%) | $385.31M(+52.7%) |
Sep 2020 | - | $252.41M(-12.3%) |
Jun 2020 | - | $287.88M(-25.9%) |
Mar 2020 | - | $388.71M(+24.6%) |
Dec 2019 | $312.06M(-6.0%) | $312.06M(+12.5%) |
Sep 2019 | - | $277.37M(+12.3%) |
Jun 2019 | - | $246.94M(-7.9%) |
Mar 2019 | - | $268.26M(-19.2%) |
Dec 2018 | $332.13M(+215.0%) | $332.13M(+31.7%) |
Sep 2018 | - | $252.21M(+39.7%) |
Jun 2018 | - | $180.58M(-61.1%) |
Mar 2018 | - | $464.16M(+340.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $105.45M(+49.2%) | $105.45M(+22.1%) |
Sep 2017 | - | $86.37M(+8.0%) |
Jun 2017 | - | $79.97M(+18.0%) |
Mar 2017 | - | $67.75M(-4.1%) |
Dec 2016 | $70.66M(+44.2%) | $70.66M(+6.2%) |
Sep 2016 | - | $66.56M(+37.0%) |
Jun 2016 | - | $48.57M(+21.9%) |
Mar 2016 | - | $39.83M(-18.7%) |
Dec 2015 | $49.01M(-39.2%) | $49.01M(-17.5%) |
Sep 2015 | - | $59.42M(-14.3%) |
Jun 2015 | - | $69.33M(-7.1%) |
Mar 2015 | - | $74.65M(-7.4%) |
Dec 2014 | $80.60M(+13.9%) | $80.60M(-0.3%) |
Sep 2014 | - | $80.84M(+53.1%) |
Jun 2014 | - | $52.79M(-0.1%) |
Mar 2014 | - | $52.83M(-25.3%) |
Dec 2013 | $70.76M(+3.3%) | $70.76M(-9.0%) |
Sep 2013 | - | $77.79M(-17.8%) |
Jun 2013 | - | $94.59M(+91.8%) |
Mar 2013 | - | $49.32M(-28.0%) |
Dec 2012 | $68.48M(+123.6%) | $68.48M(+78.8%) |
Sep 2012 | - | $38.30M(-31.5%) |
Jun 2012 | - | $55.92M(+202.2%) |
Mar 2012 | - | $18.50M(-39.6%) |
Dec 2011 | $30.63M(+24.5%) | $30.63M(+264.6%) |
Sep 2011 | - | $8.40M(-65.9%) |
Dec 2010 | $24.61M(-60.8%) | $24.61M(-27.3%) |
Sep 2010 | - | $33.84M(-46.2%) |
Dec 2009 | $62.85M(+2.7%) | $62.85M |
Dec 2008 | $61.18M | - |
FAQ
- What is Supernus Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual working capital year-on-year change?
- What is Supernus Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly working capital year-on-year change?
What is Supernus Pharmaceuticals annual working capital?
The current annual working capital of SUPN is $393.67M
What is the all time high annual working capital for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual working capital is $393.67M
What is Supernus Pharmaceuticals annual working capital year-on-year change?
Over the past year, SUPN annual working capital has changed by +$190.76M (+94.01%)
What is Supernus Pharmaceuticals quarterly working capital?
The current quarterly working capital of SUPN is $405.81M
What is the all time high quarterly working capital for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly working capital is $464.16M
What is Supernus Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, SUPN quarterly working capital has changed by +$176.04M (+76.62%)